Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Jun 15, 2020; 12(6): 651-662
Published online Jun 15, 2020. doi: 10.4251/wjgo.v12.i6.651
Published online Jun 15, 2020. doi: 10.4251/wjgo.v12.i6.651
Table 1 Baseline patient characteristics, n (%)
| Variable | n = 57 |
| Age, yr ( median and range) | 61 (41-75) |
| Sex | |
| Male | 49 (86.0) |
| Female | 8 (14.0) |
| BMI | |
| BMI < 24 | 46 (80.7) |
| BMI ≥ 24 | 11 (19.3) |
| Location of tumor | |
| Upper | 4 (7.0) |
| Middle | 20 (35.1) |
| Lower | 23 (40.4) |
| Esophagogastric junction | 5 (8.8) |
| Multiple primary tumor | 5 (8.8) |
| Histology | |
| Squamous cell carcinoma | 55 (96.5) |
| Adenocarcinoma | 2 (3.5) |
| Differentiation | |
| Poor | 13 (22.8) |
| Moderate | 33 (57.9) |
| Well | 2 (3.5) |
| Unknown | 9 (15.8) |
| Clinical T stage | |
| cT1 | 3 (5.3) |
| cT2 | 19 (33.3) |
| cT3 | 34 (59.6) |
| cT4 | 1 (1.8) |
| Clinical N stage | |
| N0 | 24 (42.1) |
| N1 | 19 (33.3) |
| N2 | 9 (15.8) |
| N3 | 5 (8.8) |
| Clinical stage group | |
| I | 2 (3.5) |
| II | 28 (49.1) |
| III | 21 (36.8) |
| IVA | 6 (10.5) |
| Therapy | |
| Surgery and neoadjuvant chemotherapy | 5 (8.8) |
| Surgery and neoadjuvant chemoradiotherapy | 17 (29.8) |
| Surgery alone | 35 (61.4) |
- Citation: Lin YB, Fu JH, Huang Y, Hu YH, Luo KJ, Wang KX, Bella AÉ, Situ DR, Chen JY, Lin T, D’Journo XB, Novoa NM, Brunelli A, Fernando HC, Cerfolio RJ, Ismail M, Yang H, the AME Thoracic Surgery Collaborative Group. Fibrin sealant for esophageal anastomosis: A phase II study. World J Gastrointest Oncol 2020; 12(6): 651-662
- URL: https://www.wjgnet.com/1948-5204/full/v12/i6/651.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i6.651